RMTI
ROCKWELL MEDICAL, INC.
NASDAQ · Healthcare · Drug Manufacturers - Specialty & Generic · US
$7.04
−3.76%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- —
- P/S forward
- 0.37x
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- 0.81x
- Price / sales
- 0.41x
- Price / cash flow
- 9.79x
Enterprise value
- Enterprise value
- $17.5M
- EV / sales
- 0.25x
- EV / EBITDA
- -9.42x
- EV / EBIT
- -3.87x
- Market cap
- $28.4M
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026